Scientists have discovered how mosquitoes develop viral immunity

Close-up of a Culex pipiens mosquito, which can transmit viruses such as West Nile and Murray Valley encephalitis.

(Medical Xpress)—Published online in the prestigious Proceedings of the National Academy of Sciences (PNAS), the team from CSIRO's Australian Animal Health Laboratory, in Geelong, have shown Vago, a protein previously identified in fruit flies, is released by infected mosquito cells, providing a warning to other cells to defend against the invading virus.

Mosquito-transmitted emerging viruses, such as dengue, Japanese encephalitis and West Nile threaten the health of our people, livestock and wildlife. Globally, dengue infects 50-100 million people and results in around 22,000 deaths annually.

According to CSIRO's Professor Peter Walker, these insect vectors present a particular biosecurity risk for Australia as they are rapidly spreading into new areas driven by a number of factors including and increased travel and trade.

"Difficulties in generating safe and effective vaccines for many of these pathogens present significant challenges due to their complex ecology and the range of hosts the viruses can infect," Professor Walker said.

This video is not supported by your browser at this time.
CSIRO’s Professor Peter Walker discusses the global biosecurity threat mosquito-borne viruses, such as dengue, pose to human health.

"Until now, very little was known about the defensive anti-viral response of insects. Unlike humans and other mammals, insects lack key components of the immune response including antibodies, T-cells and many important cytokines, such as interferon."

Using as their infection model, the research team has demonstrated that, although unrelated structurally, Vago acts in mosquitoes like human interferon.

"Mosquito cells can sense the presence of a virus by detecting its small genome, stimulating the secretion of Vago. The secreted Vago then binds to receptors on other cells, signalling an anti-viral defensive response to limit the infection," Professor Walker said.

"This is the first demonstration that such a mechanism exists in mosquitoes or any other invertebrate.

"We are now looking at how viruses such as West Nile and dengue overcome the of the mosquito and how we can use this knowledge to increase resistance to infection and decrease the efficiency of disease transmission."

CSIRO will also use this new knowledge to explore the use of Vago for the control of viruses in invertebrate aquaculture species including prawns and abalone.

Related Stories

Researchers identify new cell that attacks dengue virus

May 16, 2011

Mast cells, which can help the body respond to bacteria and pathogens, also apparently sound the alarm around viruses delivered by a mosquito bite, according to researchers at Duke-NUS Graduate Medical School in Singapore.

Recommended for you

Recorded Ebola deaths top 7,000

6 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

11 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.